Baijin Life Science HoldingsMNNGF 26 Net Current Asset Value is $0.01 as of Sep. 2025, which is 100% below its 10-year median of 5.36. GuruFocus rates MNNGF with a GF Score™ of 26/100 and a GF Value™ of $0.05. The stock has 5 warning signs investors should review. Among 554 Retail - Cyclical companies, Baijin Life Science Holdings ranks worse than 81.41% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Baijin Life Science Holdings's net current asset value per share for the quarter that ended in Sep. 2025 was $0.01.
The historical rank and industry rank for Baijin Life Science Holdings's Net Current Asset Value or its related term are showing as below:
MNNGF'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.74 Med: 5.36 Max: 37.72
Current: 7.5
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Baijin Life Science Holdings was 37.72. The lowest was 0.74. And the median was 5.36.
MNNGF's Price-to-Net-Current-Asset-Value is ranked worse than 81.41% of 554
companies
in the Retail - Cyclical industry
Industry Median: 3.075
vs MNNGF: 7.50
Baijin Life Science Holdings (OTCPK:MNNGF) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Baijin Life Science Holdings Net Current Asset Value Related Terms
Baijin Life Science Holdings Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings Net Current Asset Value Chart
For the Luxury Goods subindustry, Baijin Life Science Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Price-to-Net-Current-Asset-Value vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.01 mean?
Baijin Life Science Holdings (MNNGF) has a Net Current Asset Value of $0.01 as of Sep. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Baijin Life Science Holdings and its competitors. This is 100% below median its historical median of 5.36. Over the past decade, Baijin Life Science Holdings' Net Current Asset Value has ranged from 0.74 to 37.72. According to the industry distribution chart, Baijin Life Science Holdings ranks #451 out of 554 companies in the Retail - Cyclical industry, placing it in the top 81.4%.
Is Baijin Life Science Holdings' Net Current Asset Value too high?
Baijin Life Science Holdings' current Net Current Asset Value of $0.01 is 100% below median its 10-year median of 5.36. Over the past 10 years, this metric has ranged from a low of 0.74 to a high of 37.72. The Retail - Cyclical industry median Net Current Asset Value is 3.08. Baijin Life Science Holdings' value of $0.01 is 99.7% below this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #451 out of 554 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Net Current Asset Value compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #451 out of 554 companies for Net Current Asset Value. This places Baijin Life Science Holdings in the lower half of its industry. The industry median Net Current Asset Value is 3.08. Baijin Life Science Holdings' value of $0.01 is 99.7% below this benchmark. Historically, Baijin Life Science Holdings' own Net Current Asset Value has ranged from 0.74 to 37.72 over the past decade. While the company's 10-year median is 5.36 vs. the industry median of 3.08, Baijin Life Science Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Retail - Cyclical company?
The median Net Current Asset Value among Retail - Cyclical companies is 3.08, based on 554 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Net Current Asset Value of $0.01 is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Net Current Asset Value is 3.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Net Current Asset Value is $0.01, which is 100% below median its own 10-year median of 5.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Net Current Asset Value of $0.01. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 50% above its estimated fair value. The current Net Current Asset Value is $0.01, which is 100% below median its 10-year median of 5.36 and 99.7% below the Retail - Cyclical industry median of 3.08. Baijin Life Science Holdings' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Net Current Asset Value is $0.01 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 50% above its estimated GF Value™ of $0.05.
Key valuation signals for MNNGF:
Net Current Asset Value: $0.01 (100% below median its 10-year median of 5.36)
GF Value™: $0.05 vs. price of $0.08 (50% above fair value)
Industry Position: 99.7% below the Retail - Cyclical median (#451 of 554)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
26GF Score
Get the complete analysis for MNNGF
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
